Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.14 CAD | +16.67% | +12.00% | +75.00% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+75.00% | 11.56M | |
+52.34% | 55.7B | |
+40.71% | 39.91B | |
-6.12% | 39.57B | |
-5.56% | 28.16B | |
+15.49% | 26.3B | |
-20.30% | 18.94B | |
+31.55% | 12.17B | |
+27.10% | 12.12B | |
+0.74% | 12.12B |
- Stock Market
- Equities
- KNE Stock
- News Kane Biotech Inc.
- Kane Biotech Brief: Loss for Q3 of 2023 was ($1,197,889), an increase of 41% compared to ($851,597) for the quarter ended September 30, 2022